Probiotherapy: A novel approach to restoring skin balance
The third lecture of the evening focused on the scientific foundations of probiotherapy and its practical positioning in dermatological care. Starting from the origins of the concept, the presentation walked through the key differences between prebiotics, probiotics and postbiotics, and why ingredients commonly used in cosmetics are not equivalent to live probiotics. The mechanisms of action of topical lactobacilli, the rationale for strain-specific selection and the role of microencapsulation in maintaining bacterial viability were all addressed, alongside a comparison with other products claiming to contain live bacteria. The presentation also covered how pre, pro and postbiotic products can complement one another in acne-prone and atopic skin care, and explored the potential of probiotherapy across other indications, including intimate care.
A shared microbiome target
Acne and atopic dermatitis involve more than inflammation alone. Dysbiosis creates a shared microbiome target within familiar dermatological pathways. Skin microbiome dysbiosis, including altered microbial activity, reduced diversity, barrier dysfunction and pathobiont expansion, is a common denominator of both conditions. Established treatments remain essential, while antibiotic resistance and non-target microbiome effects reinforce the need for complementary approaches.
The take-home message of the evening: same dermatology. New biological target: the skin microbiome.
Clinical perspectives from the panel
The programme also included a panel discussion in which two dermatologists shared their practical experience with probiotherapy in patients with acne and atopic dermatitis, offering insight into how the approach is being integrated into clinical practice.
Scientific basis
The presentations were supported by peer-reviewed research, including Lebeer et al. in Cell Reports Medicine (2022) on topical lactobacilli selectively targeting skin pathobionts and inflammation, Blaser in Nature (2011) on protecting beneficial bacteria and microbiome diversity, and Sultana et al. in Applied and Environmental Microbiology (2013) on lactobacilli and epithelial barrier integrity. Presented evidence also included placebo-controlled acne data and exploratory atopic dermatitis observations.
Ready to explore what Probiotherapy could add to your market?